Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Possis bids to restore AngioJet elevation

This article was originally published in The Gray Sheet

Executive Summary

Retrospective registry data on the vascular thrombectomy system will be presented at the American College of Cardiology Annual Scientific Session in Orlando, Fla. March 6-9, the company says Feb. 22. Possis Medical attributes a drop in AngioJet sales to the September 2004 release of AiMI clinical trial results, which showed a failure of the device to reduce the size of myocardial infarctions (1"The Gray Sheet" Aug. 30, 2004, p. 9). For Q2 FY 2005 (ended Jan. 31), AngioJet sales dipped 8% year-over-year - and 7% sequentially - to $15.6 mil., Possis reports...

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts